Several brokerages have updated their recommendations and price targets on shares of CareDx (NASDAQ: CDNA) in the last few weeks: 5/31/2024 – CareDx had its “neutral” rating reaffirmed by analysts at HC Wainwright. 5/29/2024 – CareDx was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 5/21/2024 – CareDx was upgraded […]
StockNews.com lowered shares of CareDx (NASDAQ:CDNA – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning. Several other equities analysts have also recently weighed in on CDNA. HC Wainwright reiterated a neutral rating on shares of CareDx in a research note on Wednesday, May […]
HC Wainwright reaffirmed their neutral rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report published on Friday, Benzinga reports. CDNA has been the topic of a number of other reports. StockNews.com cut CareDx from a buy rating to a hold rating in a research note on Wednesday. Raymond James downgraded CareDx from […]
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
CareDx, Inc. , The Transplant Companytm ? a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers ? today.